• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inmed Pharmaceuticals Inc (NQ: INM )

    0.2220 -0.0150 (-6.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 144,270
    Open 0.2478
    Bid (Size) 0.2200 (1)
    Ask (Size) 0.2293 (10)
    Prev. Close 0.2370
    Today's Range 0.2212 - 0.2478
    52wk Range 0.1207 - 2.080
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    CBDNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis

    Performance

    YTD
    -43.08%
    -43.08%
    1 Month
    -29.34%
    -29.34%
    3 Month
    -10.41%
    -10.41%
    6 Month
    -39.82%
    -39.82%
    1 Year
    -67.11%
    -67.11%

    More News

    Read More
    InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy
    Via Investor Brand Network
    InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901
    Via Investor Brand Network
    Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
    Via Benzinga
    BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
    Via Investor Brand Network
    InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
    Via Benzinga
    US Stocks Mixed; Lowe's Cuts FY24 Forecast
    Via Benzinga
    BioMedNewsBreaks — InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD
    Via Investor Brand Network
    InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD
    Via Investor Brand Network
    InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
    Via Investor Brand Network
    InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
    Via CannabisNewsWire
    The Rising Importance Of Minor Cannabinoids In The Growing Edible Market
    Via News Direct
    Topics Cannabis
    Exposures Cannabis
    BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
    Via Investor Brand Network
    7 F-Rated Growth Stocks to Avoid Right Now: June 2024
    Via InvestorPlace
    InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases
    Via Investor Brand Network
    BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference
    Via Investor Brand Network
    Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.